(1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione

C41H44N2O8 — CID 163154530

IUPAC(1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione
SMILESCC1=C[C@@H]2/C=C/C[C@@H](C)/C=C(/C)[C@@H](O)C(=O)[C@H]3[C@H](C(=O)[C@]24C(=O)N[C@@H](Cc2c[nH]c5ccccc25)[C@@H]4[C@@H]1C)[C@H]1O[C@@H]3c2c(C)c(O)c(O)c(O)c21
InChIInChI=1S/C41H44N2O8/c1-17-9-8-10-23-14-18(2)20(4)31-26(15-22-16-42-25-12-7-6-11-24(22)25)43-40(50)41(23,31)39(49)30-29(34(46)32(44)19(3)13-17)37-27-21(5)33(45)36(48)35(47)28(27)38(30)51-37/h6-8,10-14,16-17,20,23,26,29-32,37-38,42,44-45,47-48H,9,15H2,1-5H3,(H,43,50)/b10-8+,19-13-/t17-,20-,23+,26+,29-,30+,31+,32-,37-,38+,41+/m1/s1
InChIKeyOPGBISCAYSTCSJ-RUZDOQEDSA-N
MW692.81 g/mol
LogP5.55
Rot. Bonds2

About (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione

(1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione (PubChem CID 163154530) has the molecular formula C41H44N2O8 and a molecular weight of 692.81 g/mol. Its IUPAC name is (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione.

Molecular Properties

Compound Name(1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione
PubChem CID163154530
Molecular FormulaC41H44N2O8
Molecular Weight692.81 g/mol
Exact Mass692.31
IUPAC Name(1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione
SMILESCC1=C[C@@H]2/C=C/C[C@@H](C)/C=C(/C)[C@@H](O)C(=O)[C@H]3[C@H](C(=O)[C@]24C(=O)N[C@@H](Cc2c[nH]c5ccccc25)[C@@H]4[C@@H]1C)[C@H]1O[C@@H]3c2c(C)c(O)c(O)c(O)c21
InChIInChI=1S/C41H44N2O8/c1-17-9-8-10-23-14-18(2)20(4)31-26(15-22-16-42-25-12-7-6-11-24(22)25)43-40(50)41(23,31)39(49)30-29(34(46)32(44)19(3)13-17)37-27-21(5)33(45)36(48)35(47)28(27)38(30)51-37/h6-8,10-14,16-17,20,23,26,29-32,37-38,42,44-45,47-48H,9,15H2,1-5H3,(H,43,50)/b10-8+,19-13-/t17-,20-,23+,26+,29-,30+,31+,32-,37-,38+,41+/m1/s1
InChIKeyOPGBISCAYSTCSJ-RUZDOQEDSA-N
XLogP5.55
TPSA169.18 Ų
H-Bond Donors6
H-Bond Acceptors8
Rotatable Bonds2
Heavy Atoms51
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500692.81
LogP ≤ 55.55
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'catechol_A(92)', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione?
The IUPAC name of (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione (CID 163154530) is (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione.
What is the SMILES notation for (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione?
The canonical SMILES for (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione is CC1=C[C@@H]2/C=C/C[C@@H](C)/C=C(/C)[C@@H](O)C(=O)[C@H]3[C@H](C(=O)[C@]24C(=O)N[C@@H](Cc2c[nH]c5ccccc25)[C@@H]4[C@@H]1C)[C@H]1O[C@@H]3c2c(C)c(O)c(O)c(O)c21.
What is the InChIKey of (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione?
The InChIKey is OPGBISCAYSTCSJ-RUZDOQEDSA-N. The full InChI is InChI=1S/C41H44N2O8/c1-17-9-8-10-23-14-18(2)20(4)31-26(15-22-16-42-25-12-7-6-11-24(22)25)43-40(50)41(23,31)39(49)30-29(34(46)32(44)19(3)13-17)37-27-21(5)33(45)36(48)35(47)28(27)38(30)51-37/h6-8,10-14,16-17,20,23,26,29-32,37-38,42,44-45,47-48H,9,15H2,1-5H3,(H,43,50)/b10-8+,19-13-/t17-,20-,23+,26+,29-,30+,31+,32-,37-,38+,41+/m1/s1.
What are the key properties of (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione?
(1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione has a molecular weight of 692.81 g/mol, XLogP of 5.55, 2 rotatable bonds, 6 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2S,4S,7S,8R,9S,12S,13E,16R,17Z,19R,21S,22S)-19,25,26,27-tetrahydroxy-7-(1H-indol-3-ylmethyl)-9,10,16,18,24-pentamethyl-29-oxa-6-azahexacyclo[20.6.1.02,21.04,8.04,12.023,28]nonacosa-10,13,17,23,25,27-hexaene-3,5,20-trione is sourced from PubChem (CID 163154530), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).